Xencor logo

Xencor Share Price (NASDAQ: XNCR)

$8.13

0.08

(0.99%)

Last updated on

Check the interactive Xencor Stock chart to analyse performance

Xencor stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$7.88
    Today's High:$8.13

    Day's Volatility :3.08%

  • 52 Weeks Low:$6.92
    52 Weeks High:$27.24

    52 Weeks Volatility :74.6%

Xencor Stock Returns

PeriodXencor IncSector (Health Care)Index (Russel 2000)
3 Months
-5.42%
3.6%
0.0%
6 Months
-43.88%
-7.7%
0.0%
1 Year
-52.1%
-12.6%
0.0%
3 Years
-70.09%
9.5%
-4.7%

Xencor Inc Key Stats

Check Xencor key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$8.05
Open
$7.94
Today's High
$8.13
Today's Low
$7.88
Market Capitalization
$579.9M
Today's Volume
$769.4K
52 Week High
$27.24
52 Week Low
$6.92
Revenue TTM
$146.9M
EBITDA
$-131.0M
Earnings Per Share (EPS)
$-2.36
Profit Margin
-116.44%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-29.27%

Stock Returns calculator for Xencor Stock including INR - Dollar returns

The Xencor stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xencor investment value today

Current value as on today

₹53,277

Returns

₹46,723

(-46.72%)

Returns from Xencor Stock

₹52,007 (-52.01%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Xencor Stock

0%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Xencor Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Xencor Inc

  • Name

    Holdings %

  • BlackRock Inc

    16.76%

  • PRIMECAP Management Company

    14.77%

  • Vanguard Group Inc

    12.10%

  • EcoR1 Capital, LLC

    8.62%

  • T. Rowe Price Associates, Inc.

    5.27%

  • State Street Corp

    5.17%

Analyst Recommendation on Xencor Stock

Rating
Trend

Buy

    84%Buy

    10%Hold

    5%Sell

Based on 19 Wall street analysts offering stock ratings for Xencor(by analysts ranked 0 to 5 stars)

Xencor Share Price Target

What analysts predicted

Upside of 209.96%

Target:

$25.20

Current:

$8.13

Xencor share price target is $25.20, a slight Upside of 209.96% compared to current price of $8.13 as per analysts' prediction.

Xencor Stock Insights

  • Price Movement

    In the last 6 months, XNCR stock has moved down by -47.2%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 32.73M → 43.60M (in $), with an average increase of 24.9% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -53.47M → -30.82M (in $), with an average increase of 33.8% per quarter
  • XNCR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 123.5%
  • XNCR vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 182.5%
  • Price to Sales

    ForXNCR every $1 of sales, investors are willing to pay $3.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Xencor Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$110.5M
↓ 34.36%
Net Income
$-232.6M
↑ 84.49%
Net Profit Margin
-210.53%
↓ 135.63%

Xencor Technicals Summary

Sell

Neutral

Buy

Xencor is currently in a neutral trading position according to technical analysis indicators.

Xencor Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Xencor Inc logo
1.69%
-43.88%
-52.1%
-70.09%
-76.51%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Xencor Inc

Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer. The company provides Ultomiris to treat patients with atypical hemolytic uremic syndrome, generalized myasthenia gravis, neuromyelitis optica spectrum disororder; and Monjuvi for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma; and Sotrovimab that targets the SARS-CoV-2 virus. It develops XmAb819, a bispecific antibody to treat renal cell carcinoma; XmAb541, which is in Phase I for the treatment of ovarian cancer; XmAb808, a bispecific antibody that binds to the broadly expressed tumor antigen; Vudalimab, which is in Phase II clinical trial to treat metastatic castration-resistant prostate cancer; XmAb564, to treat autoimmune diseases; XmAb662, which is in Phase I clinical trial to treat patients with solid tumors; XmAb942, which is in Phase I clinical trial for patients with Crohn's disease and ulcerative colitis; and Plamotamab, a bispecific antibody, which is in Phase I clinical trial to treat lymphoma. Further, the company develops Xaluritamig, a bispecific T-cell engager that treats prostate cancer; Obexelimab, to treat patients with immunoglobulin G4-related disease; Teropavimab and zinlirvimab to treat human immunodeficiency virus; Tobevibart, a treatment for hepatitis Delta virus infection; Novartis, an antibody drug candidate that uses XmAb Fc technologies; Xpro1595 to treat patients with Alzheimer's disease and treatment-resistant depression; Zaltenibart to treat paroxysmal nocturnal hemoglobinuria and other alternative pathway disorders; ASP2138 to treat gastric, gastroesophageal junction, and pancreatic cancers; JNJ-9401 to treat prostate cancer; and JNJ-1493 to treat B-cell malignancies. The company was incorporated in 1997 and is headquartered in Pasadena, California.
Organization
Xencor
Employees
250
CEO
Dr. Bassil I. Dahiyat Ph.D.
Industry
Health Technology

Key Management of Xencor Inc

NameTitle
Dr. Bassil I. Dahiyat Ph.D.
Co-Founder, CEO, President & Director
Mr. Bart Jan Cornelissen
Senior VP & CFO
Dr. John R. Desjarlais Ph.D.
Executive VP of Research & Chief Scientific Officer
Ms. Celia E. Eckert J.D.
Senior VP, General Counsel & Corporate Secretary
Mr. Charles Liles
Associate Director and Head of Corporate Communications & Investor Relations
Ms. Jennifer Sandoz
Senior VIce President of Human Resources
Mr. Kirk Rosemark RAC
Senior Vice President of Regulatory Affairs & Quality Assurance
Mr. Eric P. Kowack
Senior Vice President of Program Leadership & Alliance Management
Mr. Dane Vincent Leone C.F.A.
Executive VP & Chief Strategy Officer
Dr. Kenneth Hung M.D., Ph.D.
Senior Vice President of Clinical Development (Autoimmune)

Important FAQs about investing in XNCR Stock from India :

What is Xencor share price today?

Xencor share price today is $8.13 as on at the close of the market. Xencor share today touched a day high of $8.13 and a low of $7.88.

What is the 52 week high and 52 week low for Xencor share?

Xencor share touched a 52 week high of $27.24 and a 52 week low of $6.92. Xencor stock price today i.e. is closed at $8.13, lower by 70.15% versus the 52 week high.

How to invest in Xencor Stock (XNCR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xencor on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xencor Shares that will get you 0.1845 shares as per Xencor share price of $8.13 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Xencor Stock (XNCR) from India?

Indian investors can start investing in Xencor (XNCR) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Xencor stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Xencor share’s latest price of $8.13 as on August 30, 2025 at 1:29 am IST, you will get 1.2300 shares of Xencor. Learn more about fractional shares .

What are the returns that Xencor has given to Indian investors in the last 5 years?

Xencor stock has given -76.51% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?